Preliminary unaudited cash and cash equivalents is approximately $443 million as of December 31, 2023.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on IMCR:
- Immunocore announces strategic priorities and pipeline expansion ahead of 42nd Annual J.P. Morgan Healthcare Conference presentation
- Immunocore to present at the 42nd Annual J.P. Morgan Healthcare Conference
- 3 Best Stocks to Buy Now, 11/21/2023, According to Top Analysts
- Immunocore reinstated with an Overweight at JPMorgan
- Immunocore price target lowered to $72 from $74 at Mizuho
